Arvinas, Inc. Competitors
Symbol | Share Price | Market Cap | P/E Ratio | Employee Count |
---|---|---|---|---|
![]() IPSC
Century Therapeutics, Inc. |
$0.60 | $51.49 M | -2.21 | 140 |
![]() CCCC
C4 Therapeutics, Inc. |
$2.38 | $169.71 M | -1.61 | 110 |
![]() KYMR
Kymera Therapeutics, Inc. |
$44.90 | $3.15 B | -14.44 | 208 |
![]() KURA
Kura Oncology, Inc. |
$6.35 | $549.32 M | -3.04 | 192 |
![]() FHTX
Foghorn Therapeutics Inc. |
$5.88 | $328.87 M | -4.57 | 112 |
![]() BDTX
Black Diamond Therapeutics, Inc. |
$2.94 | $167.74 M | 49.17 | 24 |
![]() RARE
Ultragenyx Pharmaceutical Inc. |
$29.23 | $2.76 B | -5.01 | 1294 |
![]() CRNX
Crinetics Pharmaceuticals, Inc. |
$33.02 | $3.09 B | -8.69 | 437 |
![]() RVMD
Revolution Medicines, Inc. |
$38.37 | $7.15 B | -9.57 | 616 |
![]() STOK
Stoke Therapeutics, Inc. |
$12.06 | $658.17 M | 14.7 | 128 |
![]() RLAY
Relay Therapeutics, Inc. |
$3.56 | $615.49 M | -1.63 | 259 |
![]() PLRX
Pliant Therapeutics, Inc. |
$1.45 | $89.32 M | -0.4 | 171 |
![]() NRIX
Nurix Therapeutics, Inc. |
$12.69 | $970.14 M | -4.88 | 286 |
![]() GLUE
Monte Rosa Therapeutics, Inc. |
$5.26 | $322.98 M | 43.76 | 142 |
![]() STTK
Shattuck Labs, Inc. |
$0.82 | $39.02 M | -0.59 | 44 |